Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1486 AL 1500

Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis

Qu Y, Ma YH, Huang YY, Ou YN, Shen XN, Chen SD, Dong Q, Tan L, Yu JT.

Neurosci Biobehav Rev. 2021 Sep;128:479-486. doi: 10.1016/j.neubiorev.2021.07.007. Epub 2021 Jul 7.

The role of the immune system in Alzheimer's disease

Wu KM, Zhang YR, Huang YY, Dong Q, Tan L, Yu JT.

Ageing Res Rev. 2021 Sep;70:101409. doi: 10.1016/j.arr.2021.101409. Epub 2021 Jul 14.

Role of TREM2 in Alzheimer's Disease: A Long Road Ahead

Kulkarni B, Kumar D, Cruz-Martins N, Sellamuthu S.

Mol Neurobiol. 2021 Oct;58(10):5239-5252. doi: 10.1007/s12035-021-02477-9. Epub 2021 Jul 18.

The human connectome in Alzheimer disease - relationship to biomarkers and genetics

Yu M, Sporns O, Saykin AJ.

Nat Rev Neurol. 2021 Sep;17(9):545-563. doi: 10.1038/s41582-021-00529-1. Epub 2021 Jul 20.

Regional brain volumes relate to Alzheimer's disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study

Libowitz MR, Wei K, Tran T, Chu K, Moncrieffe K, Harrington MG, King K.

PLoS One. 2021 Jul 22;16(7):e0254332. doi: 10.1371/journal.pone.0254332. eCollection 2021.

Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease

Kim N, Lee HJ.

Int J Mol Sci. 2021 Jul 19;22(14):7697. doi: 10.3390/ijms22147697.

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

Fagan AM, Henson RL, Li Y, Boerwinkle AH, Xiong C, Bateman RJ, Goate A, Ances BM, Doran E, Christian BT, Lai F, Rosas HD, Schupf N, Krinsky-McHale S, Silverman W, Lee JH, Klunk WE, Handen BL, Allegri RF, Chhatwal JP, Day GS, Graff-Radford NR, Jucker M, Levin J, Martins RN, Masters CL, Mori H, Mummery CJ, Niimi Y, Ringman JM, Salloway S, Schofield PR, Shoji M, Lott IT; Alzheimer's Biomarker Consortium–Down Syndrome; Dominantly Inherited Alzheimer Network.

Lancet Neurol. 2021 Aug;20(8):615-626. doi: 10.1016/S1474-4422(21)00139-3.

Diabetes mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with the APOE4 genotype

Motta C, Assogna M, Bonomi CG, Mascolo AP, De Lucia V, Semprini R, Mercuri NB, Koch G, Martorana A.

Eur J Neurol. 2021 Dec;28(12):3965-3971. doi: 10.1111/ene.15039. Epub 2021 Aug 9.

Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes

Mielke MM, Frank RD, Dage JL, Jeromin A, Ashton NJ, Blennow K, Karikari TK, Vanmechelen E, Zetterberg H, Algeciras-Schimnich A, Knopman DS, Lowe V, Bu G, Vemuri P, Graff-Radford J, Jack CR Jr, Petersen RC.

JAMA Neurol. 2021 Sep 1;78(9):1108-1117. doi: 10.1001/jamaneurol.2021.2293.

Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile

Milà-Alomà M, Shekari M, Salvadó G, Gispert JD, Arenaza-Urquijo EM, Operto G, Falcon C, Vilor-Tejedor N, Grau-Rivera O, Sala-Vila A, Sánchez-Benavides G, González-de-Echávarri JM, Minguillon C, Fauria K, Niñerola-Baizán A, Perissinotti A, Simon M, Kollmorgen G, Zetterberg H, Blennow K, Suárez-Calvet M, Molinuevo JL; ALFA study.

Alzheimers Res Ther. 2021 Jul 27;13(1):134. doi: 10.1186/s13195-021-00863-y.

Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer's disease

Boada M, Martínez-Lage P, Serrano-Castro P, Costa M, Páez A.

Expert Rev Neurother. 2021 Aug;21(8):843-849. doi: 10.1080/14737175.2021.1960823. Epub 2021 Aug 4.

Brain-Derived Exosomal Proteins as Effective Biomarkers for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kim KY, Shin KY, Chang KA.

Biomolecules. 2021 Jul 3;11(7):980. doi: 10.3390/biom11070980.

Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysis

Treu SP, Plante DT.

Sleep Med. 2021 Sep;85:230-238. doi: 10.1016/j.sleep.2021.07.007. Epub 2021 Jul 13.

Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery

Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H, Dey KK, Chen PC, Yang K, Peng J.

Mol Neurodegener. 2021 Aug 12;16(1):55. doi: 10.1186/s13024-021-00474-z.

High-density lipoprotein in Alzheimer's disease: From potential biomarkers to therapeutics

Jin Y, Chifodya K, Han G, Jiang W, Chen Y, Shi Y, Xu Q, Xi Y, Wang J, Zhou J, Zhang H, Ding Y.

J Control Release. 2021 Oct 10;338:56-70. doi: 10.1016/j.jconrel.2021.08.018. Epub 2021 Aug 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias